Location: Home > Pharma China Web Edition
  • search
  • go
  • Editor's Picks
  • 3/13/2026China Private Biotech Financing Slows in February but Larger Deals Sig...
  • 3/10/2026US Weighs Policy Measures to Address China Biotech Competition
  • 3/2/20262026 Biotech Playbook: Hong Kong at the Centre of China's Globalisatio...
  • 2/26/2026China's Healthcare Reform Playbook: Boosting Births and Opening the Do...
  • 2/25/2026The Patent Term Compensation and Protection Scope in the Compensated P...
  • 2/24/2026After 230% Deal Size Explosion, China Is No Longer the 'Bargain Baseme...
  • 2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...
  • 2/16/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...
  • 2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)
  • 2/10/2026China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse (IBD...
  • 2/5/2026Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...
  • 1/29/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...
  • 1/27/2026China's Labs Pull Ahead as Global Drugmakers Invest in Biotech Pioneer...
  • 1/4/2026China Vital to Insilico's Plan to Build Biotech's AI "Einstein" for Dr...
  • 12/30/2025China's Beautiful Biotech Chaos vs West's Elegant Paralysis (Asia Time...
  • 12/23/2025NSCEB: US Faces Urgent Challenge to Stay Ahead of China in Biotech
  • 12/17/2025Understanding China's Pharmaceutical Patent Linkage System: Framework ...
  • 12/17/2025Understanding China's Pharmaceuticals Patent Linkage System: Judicial ...
  • 12/11/2025Innovative Drugs: The New Battleground in US-China Rivalry (ThinkChina...
  • 12/2/2025China Used to Be a Cash Cow for Western Companies. Now It's a Test Lab...
  • 11/20/2025China Biopharma Tracker – October 2025 (PharmaDJ)
  • 11/13/2025Innovative Antibody Therapeutic Development in China Compared with the...
  • 10/22/2025Understanding China's Longevity Market: Industry Segments, Trends and ...
  • 10/17/2025Novo vs. KBP: Fraud or Due Diligence Slipup? (FierceBiotech)
  • 10/13/2025First Drug Patent Term Extension Granted In China (Mondaq)
  • 9/23/2025Challenges and Opportunities in Oncology Drug Development and Clinical...
  • 9/23/2025China's Edge over U.S. Biotech Was Never Scientific (Washington Post)
  • 9/19/2025PRC Consolidates Pharmaceutical Supply Chain Dominance (TJF)
  • 9/19/2025Obesity in China (The Lancet)
  • 9/19/2025China's Biotechs Navigate the Demands of International Trials (Clinica...
  • Page:1/4 Total number of articles:101: [First][<<] [1] [2] [3] [4] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group